LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 1 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 1. - Dataset (ID:20309)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 21.17 | 770.25 | 1186 | 2008 | 0.5905 | 0.3664 | MN20160304_L02 | F21 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 21.17 | 770.25 | 1285 | 2008 | 0.6398 | 0.4480 | MN20160304_L02 | I19 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 21.17 | 770.25 | 1303 | 2008 | 0.6488 | 0.4626 | MN20160304_L02 | M12 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 23.39 | 770.25 | 1187 | 2244 | 0.5289 | 0.3235 | MN20160304_L02 | F21 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 23.39 | 770.25 | 1289 | 2244 | 0.5743 | 0.3961 | MN20160304_L02 | I19 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 23.39 | 770.25 | 1298 | 2244 | 0.5783 | 0.4024 | MN20160304_L02 | M12 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 25.62 | 770.25 | 1241 | 2514 | 0.4935 | 0.3223 | MN20160304_L02 | F21 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 25.62 | 770.25 | 1349 | 2514 | 0.5364 | 0.3886 | MN20160304_L02 | I19 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 25.62 | 770.25 | 1279 | 2514 | 0.5086 | 0.3459 | MN20160304_L02 | M12 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 27.84 | 770.25 | 1326 | 2833 | 0.4679 | 0.3351 | MN20160304_L02 | F21 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 27.84 | 770.25 | 1413 | 2833 | 0.4986 | 0.3811 | MN20160304_L02 | I19 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 27.84 | 770.25 | 1374 | 2833 | 0.4849 | 0.3606 | MN20160304_L02 | M12 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 30.06 | 770.25 | 1378 | 3106 | 0.4436 | 0.3353 | MN20160304_L02 | F21 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 30.06 | 770.25 | 1483 | 3106 | 0.4774 | 0.3849 | MN20160304_L02 | I19 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 30.06 | 770.25 | 1403 | 3106 | 0.4517 | 0.3473 | MN20160304_L02 | M12 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 32.28 | 770.25 | 1455 | 3392 | 0.4288 | 0.3463 | MN20160304_L02 | F21 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 32.28 | 770.25 | 1593 | 3392 | 0.4695 | 0.4045 | MN20160304_L02 | I19 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 32.28 | 770.25 | 1501 | 3392 | 0.4424 | 0.3660 | MN20160304_L02 | M12 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 34.50 | 770.25 | 1531 | 3712 | 0.4125 | 0.3536 | MN20160304_L02 | F21 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 34.50 | 770.25 | 1705 | 3712 | 0.4593 | 0.4194 | MN20160304_L02 | I19 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 34.50 | 770.25 | 1568 | 3712 | 0.4224 | 0.3680 | MN20160304_L02 | M12 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 36.73 | 770.25 | 1618 | 4086 | 0.3960 | 0.3611 | MN20160304_L02 | F21 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 36.73 | 770.25 | 1825 | 4086 | 0.4466 | 0.4309 | MN20160304_L02 | I19 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 36.73 | 770.25 | 1688 | 4086 | 0.4131 | 0.3853 | MN20160304_L02 | M12 |
| MCF 10A-H2B-mCherry | Palbociclib | 1 | 38.95 | 770.25 | 1674 | 4543 | 0.3684 | 0.3541 | MN20160304_L02 | F21 |